Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy

Chronic hepatitis B virus (HBV) infection remains a substantial public health burden worldwide. Alpha-interferon (IFNα) is one of the two currently approved therapies for chronic hepatitis B (CHB), to explore the mechanisms underlying IFNα treatment response, we investigated baseline and 24-week on-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Yu, Kangkang, Dong, Minhui, Wang, Jinyu, Yang, Feifei, Zhu, Haoxiang, Yu, Jie, Yang, Jingshu, Xie, Wentao, Mitra, Bidisha, Mao, Richeng, Wu, Feizhen, Guo, Haitao, Zhang, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336496/
https://www.ncbi.nlm.nih.gov/pubmed/35815389
http://dx.doi.org/10.1080/22221751.2022.2100831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336496/
https://www.ncbi.nlm.nih.gov/pubmed/35815389
http://dx.doi.org/10.1080/22221751.2022.2100831

Ejemplares similares